跳至主要内容
临床试验/CTRI/2025/06/088473
CTRI/2025/06/088473尚未招募不适用

OcuMap – A surgical Medical Decision-Making tool for Intraocular Lens Selection

OCULOTIX Inc1 个研究点 分布在 1 个国家目标入组 15,000 人开始时间: 2025年6月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15,000
试验地点
1
主要终点
• Phase 1: Ocumap data feeding phase: Validation of Ocumap engine after training and validation using subset.

研究概览

简要总结

All data generated as a result of this assessment will be regarded as confidential, until appropriate analysis and review by  the Investigator(s) are completed. The results of the assessment may be published or presented by the Investigator(s) after the review and such that confidential or proprietary information is not disclosed.

Prior to publication or presentation, a copy of the final text should be forwarded to the Investigator(s) or its designee, for comment. Such comments shall aim to ensure the scientific integrity of the proposed publications and/or presentations and ensure that the data and material and activities receive fair, accurate, and reasonable presentation.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • All patients presenting for cataract surgery.

排除标准

  • 未提供

结局指标

主要结局

• Phase 1: Ocumap data feeding phase: Validation of Ocumap engine after training and validation using subset.

时间窗: Screening visit, Month 3 after implant

• Phase 2: Ocumap recommendations: Proportion of patients receiving IOL such as advanced monofocal, extended range of vision, Trifocal or Bifocal intraocular lens ; toric and non-toric versions of each lens included

时间窗: Screening visit, Month 3 after implant

次要结局

  • • Surgeon time with patient during preoperative visit(s)(• Surgeon satisfaction with Ocumap, including)

研究者

发起方
OCULOTIX Inc
申办方类型
Other [software developers]
责任方
Principal Investigator
主要研究者

Dr Sathyan Parthasarathi

SATHYAN EYE CARE HOSPITAL & COIMBATORE GLAUCOMA FOUNDATION,

研究点 (1)

Loading locations...

相似试验